Robust RMP - The Key to Improving PV Standards in Asia?

Add bookmark

With the fast evolving regulatory environment in Asia, stricter guidelines on Risk Management Plan (RMP) is expected to kick in that will have far-reaching consequences. These plans are all in accordance to the goal of improving drug safety in the Asian region but addressing the problem head on will not be easy, given the hard challenges that the PV sector faces. This article considers these challenges as well as way to improve PV standards.
[inlinead]

Have Your Say
Rate this feature and give us your feedback in the comments section below

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended